LAIR1 and neoplasm: Interestingly, blockade of LAIR-1 plus anti–PD-L1 was unable to control the growth of MC38 tumors when treatment was initiated on day 9 after tumor implantation and also failed to promote infiltration or activation of lymphocyte populations under these conditions.